China’s clinical drug trial registrations exceed the U.S.’s, causing concerns| SAMR releases national standards for AI agent interconnection to establish a unified identity framework | CATL to work with U.K.-based Octopus Energy to launch battery-swapping stations in Europe
MOFCOM lays out the criteria for initiating a supply chain security investigation. The principal investigator is the person with ultimate responsibility for a clinical trial site. People may report violations of export of strategic mineral related dual-use items.
Samples selected for online review shall be ordinary goods that consumers can purchase on the market / CLP Reference: 5600/26.06.08 ; Issued: 2026-06-08
Data cited in an advertisement should comply with required qualifications / CLP Reference: 5600/26.06.03 ; Issued: 2026-06-03
Jun Luo, a Ph.D. Candidate in Intellectual Property Law at Tongji University Law School, examines a key Supreme People’s Court case from a data law perspective, analyzing its implications for data rights, platform responsibilities, user autonomy, and the evolving interface between data regulation and competition law in China
DJI and Insta360 file competing patent infringement lawsuits in Texas court | Chinese ECARX partners with U.S. May Mobility despite U.S. restrictions on Chinese connected vehicle technology | Bipartisan U.S. proposal to streamline biological data access amid China rivalry
Material changes in core or key data of financial information services are required to be reported. Samples selected for online review shall be ordinary goods that consumers can purchase on the market. Data cited in an advertisement should comply with required specifications.
Blind reliance on AI should be avoided and human judgment should be retained.
Online information may not cause confusion by fabricating issues, deepfakes, speculating and inventing.
Chinese companies are abandoning their red-chip structures after the Manus case | Trip.com fined for failing to comply with cross-border data security rules, signifying strict enforcement| China's win in Innoscience patent case against Germany's Infineon doesn't necessarily mean continued victory over the German chip giant.
